In this paper, we outline major events with regards to the HPV vaccine controversy in Japan since May 2014, highlighting long-term implications of the rapid drop in vaccination coverage and recommending how to best move forward.
Related content
![](https://www.vaccineconfidence.org/wp-content/uploads/fallback-post-thumb.png)
In June 2013 the Japanese Ministry of Health, Labor, and Welfare…
![](https://www.vaccineconfidence.org/wp-content/uploads/cerddu-jwkw-aspect-ratio-16-9-350x197.jpg)
Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…
![](https://www.vaccineconfidence.org/wp-content/uploads/Screenshot-2023-01-24-095501-aspect-ratio-16-9.png)
Overview The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…
![](https://www.vaccineconfidence.org/wp-content/uploads/mfozqocbani-aspect-ratio-16-9.jpg)
This paper explores how Japan’s response to HPV vaccine concerns has been perceived across the globe.
![](https://www.vaccineconfidence.org/wp-content/uploads/gzkhg_evwfy-aspect-ratio-16-9.jpg)
The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination.
![](https://www.vaccineconfidence.org/wp-content/uploads/d9ilr-dbedg-aspect-ratio-16-9.jpg)
This research aims to develop and evaluate a suite of feasible interventions based on artificial intelligence technologies checking extensions, real-time dashboards, and chatbots – that improve the ability to debunk misinformation, boost self-efficacy in the vaccination decision-making process.